Kadcyla ( T-DM1 ) an Amazing New Breast Cancer Drug
Kadcyla (T-DM1) is a FDA approved breast cancer drug that targets cancer cells while leaving healthy cells alone. Visit http://oacancer.com/kadcyla_t-dm1/ for more... Learn More
Lifestyle changes paired with diabetes drug may lower cancer risk for women
MD Anderson researchers focus on the combination of the diabetes prevention drug, metformin, and a lifestyle intervention of diet and physical activity... Learn More
Chemotherapy and pregnancy
Dr. Jennifer Litton, assistant professor, breast medical oncology, says chemotherapy can be given during pregnancy without harming the unborn fetus. She... Learn More
Fertility options after a cancer diagnosis
Dr. Jennifer Litton talks about why it’s important to discuss fertility options after a woman is first diagnosed with cancer.
The importance of providing hope to cancer patients
Dr. Naoto Ueno, professor of breast medical oncology, talks about the importance of providing hope to cancer patients. His perspective is... Learn More
Insight from a young ovarian cancer patient
Megan Silianoff was diagnosed with ovarian cancer at the young age 28. After four surgeries in two years (three in the... Learn More
Finding humor during cancer
Megan Silianoff found that maintaining a sense of humor during cancer treatment helped herself and family cope with the diagnosis. In... Learn More
What makes MD Anderson special
Megan Silianoff was diagnosed with cancer at age 28. After four surgeries in two years, she has no evidence of disease.... Learn More
The reality of “no evidence of disease”
Megan Silianoff was diagnosed with ovarian cancer at age 28. After four surgeries in two years, she has no evidence of... Learn More
Getting a second opinion: Why it’s important
Megan Silianoff was initially misdiagnosed with ovarian cancer and was scheduled for unnecessary surgeries and treatment. However, she followed her gut... Learn More
The upsides of having cancer
Many people might find it difficult to get an ovarian cancer diagnosis at age 28. But, looking back, Megan Silianoff says... Learn More